1. Home
  2. SATL vs PACB Comparison

SATL vs PACB Comparison

Compare SATL & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Satellogic Inc.

SATL

Satellogic Inc.

HOLD

Current Price

$3.17

Market Cap

482.3M

Sector

Technology

ML Signal

HOLD

Logo Pacific Biosciences of California Inc.

PACB

Pacific Biosciences of California Inc.

HOLD

Current Price

$1.51

Market Cap

486.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SATL
PACB
Founded
2010
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
482.3M
486.1M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
SATL
PACB
Price
$3.17
$1.51
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$6.00
$2.20
AVG Volume (30 Days)
4.6M
6.1M
Earning Date
01-01-0001
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$93,468,000.00
Revenue This Year
$16.18
$12.46
Revenue Next Year
$92.36
$12.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.04
52 Week Low
$1.26
$0.85
52 Week High
$5.93
$2.73

Technical Indicators

Market Signals
Indicator
SATL
PACB
Relative Strength Index (RSI) 46.96 37.08
Support Level $2.73 $1.36
Resistance Level $3.94 $1.73
Average True Range (ATR) 0.30 0.13
MACD -0.02 -0.00
Stochastic Oscillator 36.45 2.94

Price Performance

Historical Comparison
SATL
PACB

About SATL Satellogic Inc.

Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Share on Social Networks: